Literature DB >> 21897758

Are we satisfied with the follow-up of hypertensive and chronic kidney disease patients in outpatient clinics?

M Peppa, D Vlahakos.   

Abstract

Hypertension and chronic kidney disease constitute major health problems as they are associated with increased morbidity and mortality. Large-scale clinical trials, have emphasized the need of a strict blood pressure and early recognition of kidney disease to reduce the complications. However, the rate of hypertension control seems to be low, the prevalence of hypertension and chronic kidney disease steadily increases, indicating a gap in the management of those patients. This is due either to a poor organization of the health care system or a defective patient-physician communication. This review will try to identify possible errors in the management of hypertensive and renal failure patients in outpatient clinics and to propose ways to improve prevention and control of hypertension and chronic kidney diseases in our population.

Entities:  

Keywords:  chronic kidney disease; hypertension; outpatient clinic; patient's adherence; patients' satisfaction; quality of services

Year:  2011        PMID: 21897758      PMCID: PMC3139679     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  59 in total

1.  Reasons for adherence with antihypertensive medication.

Authors:  S Svensson; K I Kjellgren; J Ahlner; R Säljö
Journal:  Int J Cardiol       Date:  2000 Nov-Dec       Impact factor: 4.164

2.  Improved blood pressure control with a physician-nurse team and home blood pressure measurement.

Authors:  Vincent J Canzanello; Patricia L Jensen; Lora L Schwartz; Joel B Worra; Lois K Klein
Journal:  Mayo Clin Proc       Date:  2005-01       Impact factor: 7.616

3.  Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial.

Authors:  Lawrence J Appel; Catherine M Champagne; David W Harsha; Lawton S Cooper; Eva Obarzanek; Patricia J Elmer; Victor J Stevens; William M Vollmer; Pao-Hwa Lin; Laura P Svetkey; Sarah W Stedman; Deborah R Young
Journal:  JAMA       Date:  2003 Apr 23-30       Impact factor: 56.272

4.  Use of dialysis educators beyond nurses and physicians and outcomes in patients with kidney failure.

Authors:  Laura C Plantinga; Hoangmai H Pham; Nancy E Fink; Haya R Rubin; Bernard G Jaar; Neil R Powe
Journal:  Adv Chronic Kidney Dis       Date:  2005-10       Impact factor: 3.620

Review 5.  Evidence on patient-doctor communication.

Authors:  M Stewart; J B Brown; H Boon; J Galajda; L Meredith; M Sangster
Journal:  Cancer Prev Control       Date:  1999-02

6.  Prevalence of nutrition and exercise counseling for patients with hypertension. United States, 1999 to 2000.

Authors:  Philip B Mellen; Shana L Palla; David C Goff; Denise E Bonds
Journal:  J Gen Intern Med       Date:  2004-09       Impact factor: 5.128

7.  Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study.

Authors:  G S Berenson; S R Srinivasan; W Bao; W P Newman; R E Tracy; W A Wattigney
Journal:  N Engl J Med       Date:  1998-06-04       Impact factor: 91.245

Review 8.  The patient's story: integrating the patient- and physician-centered approaches to interviewing.

Authors:  R C Smith; R B Hoppe
Journal:  Ann Intern Med       Date:  1991-09-15       Impact factor: 25.391

Review 9.  Renal failure--measuring the glomerular filtration rate.

Authors:  Christian Thomas; Lothar Thomas
Journal:  Dtsch Arztebl Int       Date:  2009-12-18       Impact factor: 5.594

10.  Physician counseling for hypertension: what do doctors really do?

Authors:  Robert A Bell; Richard L Kravitz
Journal:  Patient Educ Couns       Date:  2008-03-06
View more
  1 in total

1.  Association between attendance at outpatient follow-up appointments and blood pressure control among patients with hypertension.

Authors:  Sajid Mahmood; Zahraa Jalal; Muhammad Abdul Hadi; Kifayat Ullah Shah
Journal:  BMC Cardiovasc Disord       Date:  2020-10-21       Impact factor: 2.298

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.